November 13, 2017 / 8:15 AM / a month ago

BRIEF-Xbrane Biopharma Q3 EBITDA loss at SEK ‍8.2​ mln

Nov 13 (Reuters) - XBRANE BIOPHARMA AB:

* Q3 EBITDA LOSS SEK ‍8.2​ MILLION VERSUS LOSS SEK 8.4 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below